Internal Medicine, Pulmonary Disease · Minneapolis, MN
NPI
1811917164
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
1
Hospital affiliations
920 E 28th St, Suite 700
Minneapolis, MN, 55407
Phone (612) 863-9062
Groups this clinician bills Medicare through
Medicare paid, 2024
$48K
454 services
Medicare patients, 2024
245
Average age 72
Drug cost, 2024
$1.2M
2,577 prescriptions
Company payments, 2024
$45.82
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick J Wright was code 99214 (office e&m - established), 167 times for 139 patients. In total Patrick J Wright billed 454 services in 23 codes, and Medicare paid $48K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 167 | 139 | $80.75 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 58 | 26 | $62.02 | $3,597 |
| 99204 Office E&M - New | Office | 49 | 49 | $110.60 | $5,419 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 33 | $12.33 | $407 |
| 94010 Pulmonary Function Testing | Office | 27 | 27 | $15.65 | $422 |
| 95811 Sleep Study | Office | 20 | 17 | $465.28 | $9,306 |
| 95810 Sleep Study | Office | 20 | 20 | $429.19 | $8,584 |
| 99215 Office E&M - Established | Office | 14 | 13 | $125.22 | $1,753 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $102.44 | $1,434 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $135.28 | $1,488 |
By year: 2022 $139K for 1,574 services; 2023 $93K for 927 services; 2024 $48K for 454 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88738 General Laboratory | 34 | 31 | $4.92 | $167 |
Medicare prescription drug claims, 2024
In 2024, the drug Patrick J Wright prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 305 prescriptions and refills. In total Patrick J Wright wrote 2,577 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 305 | 408 | 63 | $259K |
| Gabapentin Generic | 191 | 288 | 47 | $4,188 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 175 | 218 | 56 | $6,011 |
| Azithromycin Generic | 161 | 192 | 60 | $1,866 |
| Clonazepam Generic | 159 | 188 | 38 | $1,445 |
| Breo Ellipta Fluticasone/Vilanterol | 148 | 198 | 29 | $76K |
| Prednisone Generic | 131 | 142 | 61 | $1,040 |
| Zolpidem Tartrate Generic | 127 | 211 | 32 | $970 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 106 | 228 | 27 | $2,973 |
| Montelukast Sodium Generic | 101 | 227 | 32 | $1,385 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 95 | 140 | 36 | $19K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 50 | 89 | 27 | $15K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 43 | 43 | 11 | $2,383 |
| Modafinil Generic | 41 | 55 | 11 | $2,623 |
| Methylphenidate Hcl Generic | 40 | 40 | Under 11 | $2,564 |
Brand drugs: 905 claims; generic drugs: 1,672 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Patrick J Wright $45.82 ($45.82 in general payments such as food, travel and fees) from 3 companies. The largest payer was Inspire Medical Systems, Inc. with $45.82.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 1 | $45.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.